News

In a first, an open science platform is issuing DOIs to message board postings selected by its community.

CINCINNATI, OHIO, USA, February 14, 2023 /EINPresswire.com/ -- Therapoid, an open science company, announces the launch of Digital Object Identifiers (DOIs) for selected posts made by members in the Therapoid Forums message boards. For the first time, a researcher or student can recommend a post s/he values for future reference and citation for a DOI, which can be awarded by Therapoid.

A DOI (https://DOI.org) is not only a unique reference to help others locate the posting, it is also a way for scientists and students to promote their early ideas for discussion and to archive notes that can later develop into significant contributions to the scientific literature. As DOIs are critical for tracking scientific content, offering this important feature will help members record the initiation of their ideas.

American Impact Capital Foundation Provides Non-Fungible Token (NFT) and Cryptocurrency Holders a Route for Philanthropic and Charitable Giving

Cincinnati, OH and Westport, CT — December 12th, 2022 — Therapoid, an open science company, announces an alliance with American Impact Capital Foundation . Through this alliance, members of the Open Therapeutic' Therapoid community who wish to donate their NFTs and cryptocurrency assets to charities now have a unique pathway to do so.

Through this award, Therapoid will accelerate its Web3.0 Polygon blockchain implementation.

Cincinnati, OH, and Polygon DAO — November 8, 2022 — Therapoid an open science company was awarded a grant from the leading blockchain developer organization, the Polygon Decentralized Autonomous Organization (Polygon DAO).

Through a partnership to enhance the licensing of intellectual properties, the companies will work to jointly encourage the licensing of IP portfolios

Cincinnati, OH, and Paris, France — September 14th, 2022 — Therapoid, an open science company, and IPwe, a global platform leveraging the power of artificial intelligence, predictive analytics, and blockchain technology around smart intangible asset management, announce their collaboration to jointly advance the licensing of intellectual property.

Providing Information about the Therapoid’ Therapoid Open Science Platform.

Cincinnati, OH — May 16th, 2022 — Therapoid, an open science company, announces its Chair and interim CEO, Jason E. Barkeloo, will lead a the Therapoid booth exhibit at the American Society of Gene & Cell Therapy (ASGCT) conference at the Walter E. Washington Convention Center, 801 Mt. Vernon Pl NW, Washington DC.

Therapoid Chair and CEO to Lead Decentralized Science (DeSci) and Open Science Panel at Devconnect Week, Amsterdam, Neatherlands, Wednesday, April 20, 2022.

The Potential Impact of Decentralized Autonomous Organizations (DAO) to Open Science and Open Access. Cincinnati, OH — April 11^th, 2022 — Therapoid, an open science company, announces its Chair and interim CEO, Jason E. Barkeloo, will lead an open science, open access, and DAO panel discussion at Devconnect Week, April 18^th – April 25^th, Beurs Van Berlage, Netherlands, entitled, “The Potential Impact of Decentralized Autonomous Organizations (DAO) to Open Science and Open Access”.